Nautilus Biotechnology (San Diego)

Description

Builds a proteomics platform using iterative mapping to quantify proteins and proteoforms, helping researchers study disease biology and identify potential drug targets.

Related

• Nautilus Biotechnology ($NAUT)Develops a proteomics platform using Iterative Mapping to quantify proteins and proteoforms, helping researchers study proteome complexity…
• Recursion ($RXRX)Builds an automated AI drug discovery platform that maps disease biology from cell images and lab data to design potential medicines for…
• ResQ Biotech Private CompanyDevelops a living-cell discovery platform that biosynthesizes and functionally screens macrocyclic libraries to identify therapeutics that…
• Verge GenomicsBuilds AI models and discovery tools using multimodal human CNS data to identify drug targets, match patients, and support neurological…
• EvolutionaryScaleBuilds AI models for biology and protein design, offering ESM3 tools and open resources for scientists studying proteins and health-related…
• Ditto BiosciencesDiscovers drug candidates by using parasite biology and AI to identify parasite proteins that could treat autoimmune diseases driven by an…
• InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics…
• Institute for Systems BiologyConducts systems biology research on cancer, health, infectious disease, chronic illness, and environment, while providing education,…
• CalicoStudies aging and healthspan biology, combining research, computational biology, machine learning, and drug development to turn biological…
• Enveda BiosciencesBuilds a drug discovery platform that analyzes natural chemistry to help drug hunters find potential medicines from largely unexplored…
• Neumora TherapeuticsDevelops treatments for brain diseases, advancing CNS-targeted medicines and precision approaches to understand disease biology and…
• Leash BiosciencesBuilds protein-molecule interaction datasets by screening many compounds against proteins to support machine-learning drug design and…